Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study - Concepedia

Concepedia

Publication | Closed Access

Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study

538

Citations

42

References

2013

Year

Jadwiga A. Wedzicha, Marc Decramer, Joachim H. Ficker, Dennis E. Niewoehner, Thomas Sandström, Angel Fowler Taylor, Peter D’Andrea, Christie Arrasate, Hungta Chen, Donald Banerji

The Lancet Respiratory Medicine

AsthmaAdvanced Lung DiseaseParallel-group StudyPulmonary MedicineMedicineDual Bronchodilator Qva149Pulmonary Disease

References

	Year	Citations

Page 1